MedTrace Logo

Development of New Personalised 3D Preclinical Models of Pancreatic Neuroendocrine Tumours

NCT06121622 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 70

Last updated 2025-05-01

No results posted yet for this study

Summary

The goal of this prospective observational study is to generate new personalised 3D preclinical models of pancreatic neuroendocrine tumors. The models will be exploited for studying the mechanisms underlying disease development and progression, as well as for performing drug testing. For the development of the newly proposed models, patients' surgical specimens will be evaluated by the Pathological Unit. If the presence of pathological material in excess, not required for the routine diagnostic procedure, is confirmed, such material will be employed for the generation of the proposed personalised models.

Conditions

  • Pancreatic Neuroendocrine Tumor

Sponsors & Collaborators

  • IRCCS San Raffaele

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-01-16
Primary Completion
2029-11-30
Completion
2029-12-31

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06121622 on ClinicalTrials.gov